-
immunotherapy using cutting-edge protein engineering with directed evolution. The lab has developed therapeutics that are currently in clinical trials, such as ST-067 (a "decoy-resistant" IL-18), MDNA-11 (CD122
-
provide fresh tumor specimens and PDX models, novel engineered murine models, state of the art-AI-enabled drug screening in microtumors and cancer cells, and more. Responsibilities The Clurman lab is
-
to advancing cancer research and developing new treatments. Our research integrates functional and clinical genomics to uncover molecular mechanisms driving cancer treatment resistance and accelerate
-
stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. A Post-Doctoral Research Fellow training position is available to study the molecular mechanisms
-
stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. A Post-Doctoral Research Fellow training position is available to study the molecular mechanisms